Federated analyses of multiple data sources in drug safety studies.

Rolf GedeborgWilmar IglBodil SvennbladPeter WilénBénédicte DelcoigneKarl MichaëlssonRickard LjungNils Feltelius

Published in: Pharmacoepidemiology and drug safety (2022)

Federated Analyses require competent and active involvement of all collaborating parties but have the potential to facilitate collaboration across institutional and national borders and improve the precision of postmarketing drug safety studies.

Keyphrases

case control
electronic health record
drinking water
adverse drug
quality improvement
drug induced
risk assessment
artificial intelligence